OUR TEAM: Darren Thompson


Darren.jpg

Darren Thompson
Director
darren.thompson@scimitar-inc.com

 

Darren has 18 years of Life Science industry experience in Pharmaceuticals and Medical Devices. A background in molecular biology coupled with solid business acumen and a history of success leading complex cross functional teams on strategically important projects.  Prior to Scimitar Darren held leadership roles as Head of Project and Portfolio Management with Merck KGaA, and also with Life Technologies (now part of Fisher Scientific).  

Prior to this Darren spent several years as a management consultant in the life science practice with PRTM where he led projects that improved performance, drove growth, and positively impacted the P&L.

Darren earned his MBA from University of Warwick Business School, and his BSc in Genetics from the University of Swansea, UK.


Project Experience

  • Portfolio Management: Led the Portfolio Management group for a division of Merck KGaA. Developed and implemented the portfolio management process to gather data, evaluate opportunities and select from a pool of potential investments using empirical data driven methods.

  • Project and Portfolio Management: Led a project to create the Portfolio and Project management function for a fast pacedpharmaceutical company. Developed process, hired and trained staff, and built out the full scale infrastructure to enable data driven decision making, and management of execution.

  • Critical Project Recovery: A mid-sized medical device company was struggling to deliver a strategically important new product development project on schedule. With only four months left until a key deadline to enter clinical trials Darren assumed leadership of the cross-functional project team, identified root cause, developed solutions to shorten the timeline and manage risk. The project was successfully completed on schedule, left unchanged it would have been three months late in starting clinical trials.

  • Quality/Regulatory –  A fortune 500 IVD company under investigation by the FDA needed to validate and justify it’s Quality Systems. Led the project to review all systems for product development and manufacturing across all products to demonstrate that the client was in compliance with CFR 820 and ISO 13485. 

  • New Product Development – A large medical device company had burgeoning R&D costs, but very few new product introductions, most of which were significantly delayed. Led a team to evaluate the product development process, design a more effective alternative, and work at all levels in the organization to implement the changes. The result was a leaner process that today brings more products to market in less time.

  • Manufacturing facility build out: Led a project to coordinate 3 major cross enterprise projects designed to build out a new 30,000 sq ft. manufacturing facility for biological pharmaceuticals. Transfer in, and scale up a new clinical stage product, and coordinate all required site functions to ensure a successful, on time, within budget start of engineering and qualification runs on the combined new plant / new product combination.